Warren A. Kaplan, PhD, JD, MPH
Clinical Assistant Professor
Boston University School of Public Health
Dept of Global Health

PhD, Boston University
MPH, Boston University School of Public Health
MS, Texas A & M University
JD, Suffolk University



Intellectual property, trade and public health
Access to medicines and devices
Pharmaceutical policy
Prevention and treatment of diabetes
Pharmaceutical pricing and market dynamics


IDENTIFYING LINKS BETWEEN DRUG QUALITY AND ANTIMICROBIAL RESISTANCE
05/18/2017 - 05/31/2017 (PI)
United States Pharmacopeial Convention

Operational Research on Supply and Delivery of Pediatric HIV Formulations in Resource-Poor Areas
07/07/2005 - 12/31/2005 (PI)
United Nations Children's Fund




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kaplan WA, Ashigbie PG, Brooks MI, Wirtz VJ. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies. J Pharm Policy Pract. 2017; 10:17.View Related Profiles. PMID: 28523128.
  2. Sharma A, Kaplan WA. Challenges constraining access to insulin in the private-sector market of Delhi, India. BMJ Glob Health. 2016 Nov; 1(3):e000112. PMID: 28588966.
  3. Lee YH, Ang TF, Chiang TC, Kaplan WA. Growing concerns and controversies to Taiwan''s National Health Insurance-what are the lessons from mainland China, South Korea and Singapore? Int J Health Plann Manage. 2016 Oct 10. PMID: 27723118; DOI: 10.1002/hpm.2387;.
  4. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 Oct 04; 134(14):e305-e306.View Related Profiles. PMID: 27698055.
  5. Kaplan WA, Beall RF. The global intellectual property ecosystem for insulin and its public health implications: an observational study. J Pharm Policy Pract. 2017; 10:3. PMID: 27446593; DOI: 10.1186/s40545-016-0072-8;.
  6. Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. Liberating data to combat NCDs. Lancet Diabetes Endocrinol. 2016 Jun; 4(6):482-3. PMID: 27207276; DOI: 10.1016/S2213-8587(16)30054-7;.
  7. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85.View Related Profiles. PMID: 27217433; PMCID: PMC4880457; DOI: 10.1161/CIRCULATIONAHA.115.008722;.
  8. Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. (2016). Lancet Diabetes & Endocrinology. 2016. View Publication
  9. Sharma A, Kaplan WA, Chokshi M, Zodpey SP. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12. Health Policy Plan. 2016 Sep; 31(7):884-96. PMID: 26976803; DOI: 10.1093/heapol/czw008;.
  10. Beall RF, Nickerson JW, Kaplan WA, Attaran A. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products? PLoS One. 2016; 11(2):e0148939. PMID: 26910128; PMCID: PMC4766186; DOI: 10.1371/journal.pone.0148939;.
Showing 10 of 26 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 26 publications over 11 distinct years, with a maximum of 10 publications in 2016

YearPublications
20031
20062
20091
20101
20112
20124
20132
20141
20151
201610
20171
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Kaplan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department